Identification and treatment of gestational trophoblastic neoplasia located in the cesarean scar
Identification and treatment of gestational trophoblastic neoplasia located in the cesarean scar
复制标题
剖宫产疤痕妊娠滋养细胞肿瘤的识别和治疗
DOI:
10.1002/ijgo.12417
复制
发表时间:
2018-05-01
影响因子:
3.8
通讯作者:
Xiang, Yang
中科院分区:
文献类型:
--
作者:
Wang, Xiaoyu;Li, Yuan;Xiang, Yang
ObjectiveTo identify the clinical characteristics of, and the diagnostic and therapeutic strategies for, gestational trophoblastic neoplasia (GTN) located in the cesarean scar.MethodsThe present retrospective analysis was conducted among patients diagnosed with GTN located in the cesarean scar at Peking Union Medical College Hospital, Beijing, China, between June 1, 2006, and May 31, 2016. Clinical features, diagnostic and therapeutic procedures, and outcomes were reviewed.ResultsOf 938 women diagnosed with GTN, 31 (3.3%) patients had GTN located in the cesarean scar. Irregular vaginal bleeding was the main clinical manifestation. Twenty (65%) patients received an accurate diagnosis based on a history of molar pregnancy/a high -human chorionic gonadotropin level/typical imaging presentations. The remaining 11 patients were initially misdiagnosed; the definitive diagnosis was made by pathology. All patients received chemotherapy; 22 (71%) women also underwent hysterectomy or localized uterine lesion resection because of chemoresistant lesions. All patients had a complete remission; at a median follow-up of 35months, only 1 (3%) woman had a relapse.ConclusionOwing to its rarity and nonspecific symptoms, GTN located in the cesarean scar is prone to misdiagnosis. In patients without typical manifestations, the definitive diagnosis often relies on pathology. For treatment, uterine lesion resection is a useful adjunct to chemotherapy.Definitive diagnosis of gestational trophoblastic neoplasia in a cesarean scar often required pathological examination; uterine lesion resection was a useful adjunct to chemotherapy.